Clinical Trial Update: Gabapentin to Reduce Alcohol and Improve Viral Load Suppression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at Boston Medical Center is evaluating gabapentin to reduce alcohol consumption and improve HIV viral load suppression in people with H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• HIV Infection

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Boston Medical Center | Conditions: HIV, Heavy Drinking | Phase 2 | Status: RECRUITING